Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease

Table 2 Highlights baseline characteristics of patient’s demographics and clinical and endoscopic descriptions

	All patients CD and IC n = 27	CD n = 20
Age at diagnosis year	13.46 (2.40)	13.48 (2.02)
Male %	74%	75%
Medications ratio (%)
Biological alone or combination therapy	12/27 (44.4%)	11/20 (55%)
Immune modulators with no biologic combination	8/27 (30%)	5/20 (25%)
5 ASA +- steroids	4/27 (15%)	3/20 (15%)
Steroids alone	2/27 (7%)	0/20 (0%)
Antibiotic alone	1/27 (4%)	1/20 (5%)
Phenotype%
Inflammatory	93%	93%
Stricturing	7%	7%
Duration of disease year	1.7 (2.32)	2.1 (2.57)
BMI percentile	57 (32.9)	58.18 (35.83)
PCDAI	10.2 (12.5)	9.8 (11.6)
SB transit time min	233 (115.4)	241(184.99)
Days between MRE and WCE days	4.19 (1.88)	4 (1.90)

Baseline characteristics of all patients expressed in mean (SD) and the ratio (percentage). CD Crohn’s disease, IC indeterminate colitis, ASA amino salicylate, SB small bowel, BMI body mass index, MRE magnetic resonance enterography, PCDAI pediatric Crohn’s disease activity index WCE wireless capsule endoscopy.